What Pharmacists Should Know About CBD

This program has been developed to support pharmacy professionals who want to learn more about cannabidiol (CBD), a growing option for patients seeking alternative treatment.

$50.00

$25 Member Price Become a Member
This product is accessible only by members. log in or become a member

Description

Description:

The data for cannabis can feel overwhelming, especially in the last few years. The challenge is to sift through the noise and find clinically relevant information. With emerging topics, clinical experience is just as valuable as medical literature. This course outlines what is the pharmacology of cannabidiol (CBD), reviews the medical evidence for CBD use, discusses dosing and dosage forms, adverse effects of CBD, CBD use with tetrahydrocannabinol (THC), and briefly summarizes other emerging cannabinoids.

Learning objectives:

By the end of this course, you should be able to:

  • Examine the basic pharmacology and pharmacokinetics of cannabidiol (CBD)
  • Review the evidence for the medical use of CBD
  • Describe the dosing and dosage forms of CBD-only medical and recreational products
  • Compare and contrast the adverse effects, drug interactions, and contraindications of CBD with THC
  • Understand how CBD and THC are used together by medical cannabis authorizers and cannabis clinics
  • Briefly review the emerging evidence for other non-THC cannabinoids

Course outline:

  • What Pharmacists Should Know About CBD
  • Final multiple-choice exam
  • Program Evaluation

Course at a glance:

  • 0.75 hours to complete
  • 0.75 CEUs
  • Available until April 4, 2023
  • Online
  • Accreditation: 8003-2022-3418-I-P
  • Completion requirement: Complete the course’s online modules, complete the multiple-choice exam with a score of 70 per cent or higher (two attempts), and complete the program evaluation.

Who should take this course:

This course provides pharmacists with useful information they can apply to their everyday practice. Pharmacy technicians are also welcome to enroll.

Development Team:

  • Michael A. Beazely, BSP, PhD
  • Neil D’Souza, B. Pharm, RPh
  • Rahim Dhalla, PharmD, MCPHS, RPh